Structural and Functional Alterations of Subcutaneous Small Resistance Arteries in Severe Human Obesity

[1]  J. Tune,et al.  Leptin and mechanisms of endothelial dysfunction and cardiovascular disease , 2008, Current hypertension reports.

[2]  Eric Vicaut,et al.  Impaired Tissue Perfusion: A Pathology Common to Hypertension, Obesity, and Diabetes Mellitus , 2008, Circulation.

[3]  E. Schiffrin,et al.  Selective Mineralocorticoid Receptor Blocker Eplerenone Reduces Resistance Artery Stiffness in Hypertensive Patients , 2008, Hypertension.

[4]  U. Smith,et al.  Inflamed Adipose Tissue: A Culprit Underlying the Metabolic Syndrome and Atherosclerosis , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[5]  C. de Ciuceis,et al.  Structural alterations of subcutaneous small-resistance arteries may predict major cardiovascular events in patients with hypertension. , 2007, American journal of hypertension.

[6]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[7]  K. Thygesen,et al.  Abstract 2595: Small Artery Structure is an Independent Predictor of Cardiovascular Events in Essential Hypertension , 2006 .

[8]  E. Schiffrin,et al.  Angiotensin Receptor Blocker Added to Previous Antihypertensive Agents on Arteries of Diabetic Hypertensive Patients , 2006, Hypertension.

[9]  H. Vincent,et al.  Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans , 2006, International Journal of Obesity.

[10]  J. Staessen,et al.  Obesity is associated with increased arterial stiffness from adolescence until old age , 2005, Journal of hypertension.

[11]  J. Twisk,et al.  The metabolic syndrome, cardiopulmonary fitness, and subcutaneous trunk fat as independent determinants of arterial stiffness: the Amsterdam Growth and Health Longitudinal Study. , 2005, Archives of internal medicine.

[12]  D. Rizzoni,et al.  Small artery structure and hypertension: adaptive changes and target organ damage. , 2005, Journal of hypertension.

[13]  G. Mancia,et al.  Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives , 2004, Journal of hypertension.

[14]  G. Grassi.  Counteracting the sympathetic nervous system in essential hypertension , 2004, Current opinion in nephrology and hypertension.

[15]  C. Stehouwer,et al.  Impaired Microvascular Function in Obesity: Implications for Obesity-Associated Microangiopathy, Hypertension, and Insulin Resistance , 2004, Circulation.

[16]  J. Twisk,et al.  Central fat mass versus peripheral fat and lean mass: opposite (adverse versus favorable) associations with arterial stiffness? The Amsterdam Growth and Health Longitudinal Study. , 2004, The Journal of clinical endocrinology and metabolism.

[17]  E. Schiffrin,et al.  Persistent Remodeling of Resistance Arteries in Type 2 Diabetic Patients on Antihypertensive Treatment , 2004, Hypertension.

[18]  J. Twisk,et al.  Current and adolescent body fatness and fat distribution: relationships with carotid intima–media thickness and large artery stiffness at the age of 36 years , 2004, Journal of hypertension.

[19]  C. de Ciuceis,et al.  Prognostic Significance of Small-Artery Structure in Hypertension , 2003, Circulation.

[20]  E. Porteri,et al.  Relationships between coronary flow vasodilator capacity and small artery remodelling in hypertensive patients. , 2003, Journal of hypertension.

[21]  A. Heagerty,et al.  Vascular Structural and Functional Changes in Type 2 Diabetes Mellitus: Evidence for the Roles of Abnormal Myogenic Responsiveness and Dyslipidemia , 2002, Circulation.

[22]  S. Beske,et al.  Sympathetic Neural Activation in Visceral Obesity , 2002, Circulation.

[23]  E. Porteri,et al.  Structural Alterations in Subcutaneous Small Arteries of Normotensive and Hypertensive Patients With Non–Insulin-Dependent Diabetes Mellitus , 2001, Circulation.

[24]  G. Mancia,et al.  Adrenergic and Reflex Abnormalities in Obesity-Related Hypertension , 2000, Hypertension.

[25]  E. Schiffrin,et al.  Structure and Mechanical Properties of Resistance Arteries in Hypertension: Role of Adhesion Molecules and Extracellular Matrix Determinants , 2000, Hypertension.

[26]  E. Schiffrin,et al.  Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. , 2000, Circulation.

[27]  Daniel J Buysse,et al.  Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. , 1999, Sleep.

[28]  A. Heagerty,et al.  Endothelial dysfunction in human intramyocardial small arteries in atherosclerosis and hypercholesterolemia. , 1998, American journal of physiology. Heart and circulatory physiology.

[29]  C. Sartori,et al.  Insulin as a vascular and sympathoexcitatory hormone: implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. , 1997, Circulation.

[30]  E. Schiffrin,et al.  How to assess vascular remodelling in small and medium‐sized muscular arteries in humans , 1997, Journal of hypertension.

[31]  A. Baron,et al.  Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. , 1996, The Journal of clinical investigation.

[32]  G. Mancia,et al.  Radial artery compliance in young, obese, normotensive subjects. , 1995, Hypertension.

[33]  A. Heagerty,et al.  In vitro responses of human peripheral small arteries in hypercholesterolemia and effects of therapy. , 1995, Circulation.

[34]  G. Mancia,et al.  Sympathetic activation in obese normotensive subjects. , 1995, Hypertension.

[35]  N. Reichek,et al.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[36]  H. Danielsen,et al.  Morphological and functional characteristics of isolated resistance vessels in advanced uraemia. , 1986, Clinical science.

[37]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[38]  N Reichek,et al.  Echocardiographic Determination of Left Ventricular Mass in Man: Anatomic Validation of the Method , 1977, Circulation.

[39]  W. Elliott,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2008 .

[40]  Daniel J Buysse,et al.  Sleep–Related Breathing Disorders in Adults: Recommendations for Syndrome Definition and Measurement Techniques in Clinical Research , 2000 .

[41]  E. Schiffrin,et al.  Mechanics and composition of human subcutaneous resistance arteries in essential hypertension. , 1999, Hypertension.

[42]  E. Giltay,et al.  Arterial compliance and distensibility are modulated by body composition in both men and women but by insulin sensitivity only in women , 1999, Diabetologia.